Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Laurence B Givner"'
Autor:
Adriana Sarmiento Clemente, Sheldon L Kaplan, William J Barson, Philana Ling Lin, José R Romero, John S Bradley, Tina Q Tan, Pia S Pannaraj, Laurence B Givner, Kristina G Hultén
Publikováno v:
Journal of the Pediatric Infectious Diseases Society, vol 11, iss 9
Measures to limit SARS-CoV-2 transmission in 2020 reduced other viral infections. Among 7 US children’s hospitals, invasive pneumococcal disease cumulative incidence decreased by 46% in 2020 vs 2017-2019. Limited droplet transmission of pneumococci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ad102fbc8fc6eec406c9eee26ac299
https://escholarship.org/uc/item/8tj2747h
https://escholarship.org/uc/item/8tj2747h
Autor:
Liset Olarte, Sheldon L. Kaplan, William J. Barson, José R. Romero, Philana Ling Lin, Tina Q. Tan, Jill A. Hoffman, John S. Bradley, Laurence B. Givner, Edward O. Mason, Kristina G. Hultén
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 2, Pp 405-405 (2018)
Externí odkaz:
https://doaj.org/article/61e03fdbaff94cca8bdbec05ba3e577d
Autor:
Thomas B. Russell, Emily K. Rinker, Laurence B. Givner, Thomas W. McLean, Claire S. Dillingham
Publikováno v:
Pediatrics. 141:S421-S424
Sirolimus is an effective therapy for children with kaposiform hemangioendothelioma with or without the Kasabach-Merritt phenomenon. We report the case of a child with kaposiform hemangioendothelioma and the Kasabach-Merritt phenomenon who developed
Autor:
Philana Ling Lin, William J. Barson, Laurence B. Givner, Jose R. Romero, Pia S. Pannaraj, Tina Q. Tan, Sheldon L. Kaplan, John S. Bradley, Kristina G. Hulten
Publikováno v:
Pediatrics. 144
BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in the United States in 2010. We describe invasive pneumococcal disease (IPD) in children at 8 children’s hospitals in the US from 2014 to 2017. METHODS: Children with IP
Autor:
Catherine L. Passaretti, David H. Priest, Cynthia Snider, Susan L. DeCamp-Freeze, Misty D. Garner, Andrea B. McQuaigue, Laurence B. Givner, Melissa Morgan
Publikováno v:
Infection control and hospital epidemiology. 40(2)
Autor:
William J. Barson, Tina Q. Tan, Liset Olarte, Ryan M. Barson, Edward O. Mason, Sheldon L. Kaplan, Philana Ling Lin, Laurence B. Givner, John S. Bradley, Kristina G. Hulten, Jose R. Romero, Jill A. Hoffman
Publikováno v:
Clinical Infectious Diseases. 61:767-775
Background The impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal meningitis (PM) in US children is unknown. We compared the serotype distribution, antibiotic susceptibility, hospital course, and outcomes of children with PM 3
Autor:
Jose R. Romero, Laurence B. Givner, Jill A. Hoffman, Edward O. Mason, Tina Q. Tan, Philana Ling Lin, William J. Barson, John S. Bradley, Sheldon L. Kaplan, Kristina G. Hulten, Liset Olarte
Publikováno v:
The Pediatric infectious disease journal. 36(12)
Pneumococcal osteoarticular infections (OAIs) are an uncommon manifestation of invasive pneumococcal disease (IPD). We describe the demographic characteristics, hospitalization rate, serotype distribution and antibiotic susceptibility of children wit
Publikováno v:
Pediatrics. 139
* Abbreviations: BCH — : Brenner Children’s Hospital DDCCP — : Declan Donoghue Collaborative Care Program EMR — : electronic medical record PCP — : primary care physician UCMC — : undiagnosed complex medical conditions WFBH — : Wake For
Autor:
Edward O. Mason, Tina Q. Tan, John S. Bradley, Sheldon L. Kaplan, Laurence B. Givner, Kristina G. Hulten, Jill A. Hoffman, William J. Barson, Philana Ling Lin, Jose R. Romero, Liset Olarte
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 7(3)
We identified 53 infants aged 0-60 days with invasive pneumococcal disease (IPD) at 8 children's hospitals in the United States (2005-2015). After the introduction of 13-valent pneumococcal conjugate vaccine (PCV13), IPD caused by PCV13 serotypes dec
Autor:
Sheldon L. Kaplan, Philana Ling Lin, Edward O. Mason, Tina Q. Tan, Jose R. Romero, William J. Barson, John S. Bradley, Laurence B. Givner, Jill A. Hoffman
Publikováno v:
Pediatric Infectious Disease Journal. 32:203-207
The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced for routine administration to infants and children in 2010 in the United States. We have monitored clinical and microbiologic features of invasive pneumococcal infections among child